Sign in Subscribe
Scientists

WDR20 Regulates Activity of USP12 x UAF1 Deubiquitinating Enzyme Complex

Strategic Insights

— 1 min read

Scientists at Dana-Farber Cancer Institute have uncovered new insights into the regulation of the USP12 x UAF1 deubiquitinating enzyme complex. The USP12 x UAF1 complex plays a crucial role in various cellular processes, including DNA repair and cell cycle regulation. A study published in the Journal of Biological Chemistry has revealed that WDR20, a WD40-repeat containing protein, binds and stimulates the enzymatic activity of the USP12 x UAF1 complex. Furthermore, the researchers demonstrated the purification of a ternary USP12 x UAF1 x WDR20 complex and showed that WDR20 does not affect the FA pathway or DNA damage responses.

Key Takeaways:

  • WDR20 binds and stimulates the enzymatic activity of the USP12 x UAF1 complex.
  • The USP12 x UAF1 x WDR20 complex is a ternary complex with WDR20 acting as a stimulatory subunit.
  • WDR20 does not affect the FA pathway or DNA damage responses.
  • The study provides a model for understanding the regulation of the USP12 x UAF1 complex in various cellular processes.
  • WDR20's role in regulating the USP12 x UAF1 complex has implications for understanding its potential involvement in cancer and other diseases.
  • The study highlights the importance of identifying proteins that interact with deubiquitinating enzymes and their complexes.

Statistics:

  • The study was published in the Journal of Biological Chemistry in 2010.
  • The research was conducted at the Dana-Farber Cancer Institute in Boston, Massachusetts, USA.
  • The USP12 x UAF1 complex is a deubiquitinating enzyme complex involved in various cellular processes, including DNA repair and cell cycle regulation.
  • WDR20 is a WD40-repeat containing protein that acts as a stimulatory subunit for the USP12 x UAF1 complex.
  • The study demonstrated the purification of a ternary USP12 x UAF1 x WDR20 complex.

Sources:

  • Journal of Biological Chemistry, 2010;285(15):11252-7.
  • Y. Kee et al., Dana-Farber Cancer Institute, Department of Radiation Oncology, Boston, Massachusetts 02115, United States.
  • Science Letter editors, 2011.
  • NewsRx.com, 2011.

Read more